Unique ID issued by UMIN | UMIN000020592 |
---|---|
Receipt number | R000023714 |
Scientific Title | Investigation of the efficacy of social contribution for patients with NAFLD to motivate to start and continue the treatment. |
Date of disclosure of the study information | 2016/01/18 |
Last modified on | 2020/08/01 22:46:11 |
Investigation of the efficacy of social contribution for patients with NAFLD to motivate to start and continue the treatment.
Investigation of the efficacy of social contribution for NAFLD patients to motivate the treatment.
Investigation of the efficacy of social contribution for patients with NAFLD to motivate to start and continue the treatment.
Investigation of the efficacy of social contribution for NAFLD patients to motivate the treatment.
Japan |
NAFLD
Hepato-biliary-pancreatic medicine |
Others
NO
To investigate whether decreased transaminase level makes the contribution to UNICEF is useful for NAFLD to start and continue the treatment .
Safety
Confirmatory
Pragmatic
Not applicable
Improvement of NAFLD at 3 years after starting this intervention
Improvement of ALT levels at 3 month after starting this intervention
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
2
Treatment
Behavior,custom |
Patients will continue the treatment and differences of paired ALT levels (ALT at every 3 month - ALT at baseline) will be evaluated at every 3 month after registration of this study. 1 IU/L of differences of paired ALT levels will be converted 10-yen and total amount will be contributed to UNICEF.
Patients will continue the treatment and differences of paired ALT levels (ALT at every 3 month - ALT at baseline) will be evaluated at every 3 month after registration of this study. Differences will not be contributed to UNICEF. (control group)
Not applicable |
Not applicable |
Male and Female
NAPLD patients with ALT levels were persisting upper 31 IU/L for 1 year or more.
patient with other chronic liver disease.
patient with pregnancy.
Drug induced fatty liver
patient with disease associated with fatty liver (polycystic ovary disease, hypothyroidism, obstructive sleep apnea syndrome, hypopituitarism, hypogonadism, after an operation of pancreaticoduodenectomy)
50
1st name | Kazuhito |
Middle name | |
Last name | Kawata |
Hamamatsu University School of Medicine
Department of Internal Medicine II
4313192
1-20-1 Handayama Higashiku Hamamatsu
053-435-2263
kawata@hama-med.ac.jp
1st name | Kazuhito |
Middle name | |
Last name | Kawata |
Hamamatsu University School of Medicine
Department of Internal Medicine II
4313192
1-20-1 Handayama Higashiku Hamamatsu
053-435-2263
kawata@hama-med.ac.jp
Hamamatsu University School of Medicine
none
Self funding
Hamamatsu University School of Medicine
1-20-1 Handayama Higashiku Hamamatsu
053-435-2680
rinri@hama-med.ac.jp
NO
2016 | Year | 01 | Month | 18 | Day |
Unpublished
33
Completed
2015 | Year | 08 | Month | 21 | Day |
2015 | Year | 08 | Month | 04 | Day |
2015 | Year | 10 | Month | 20 | Day |
2020 | Year | 07 | Month | 31 | Day |
2020 | Year | 07 | Month | 31 | Day |
2020 | Year | 07 | Month | 31 | Day |
2020 | Year | 08 | Month | 31 | Day |
2016 | Year | 01 | Month | 16 | Day |
2020 | Year | 08 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023714
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |